0001019056-16-001465.txt : 20160805
0001019056-16-001465.hdr.sgml : 20160805
20160805203429
ACCESSION NUMBER: 0001019056-16-001465
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160803
FILED AS OF DATE: 20160805
DATE AS OF CHANGE: 20160805
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aptevo Therapeutics Inc.
CENTRAL INDEX KEY: 0001671584
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811567056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
BUSINESS PHONE: 206-838-0500
MAIL ADDRESS:
STREET 1: 2401 4TH AVE.
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stromatt Scott C
CENTRAL INDEX KEY: 0001679975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37746
FILM NUMBER: 161812358
MAIL ADDRESS:
STREET 1: 2401 4TH AVENUE
STREET 2: SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
stromatt_4.xml
OWNERSHIP DOCUMENT
X0306
4
2016-08-03
0
0001671584
Aptevo Therapeutics Inc.
APVO
0001679975
Stromatt Scott C
2401 4TH AVENUE, SUITE 1050
SEATTLE
WA
98121
0
1
0
0
Chief Medical Officer and SVP
Common Stock
8412
D
Restricted Stock Unit
2016-08-03
4
A
0
54762
0
A
Common Stock
54762
54762
D
Restricted Stock Unit
2016-08-03
4
A
0
78124
0
A
Common Stock
78124
78124
D
Shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective on August 1, 2016.
Each restricted stock unit represents the right of Mr. Stromatt to receive one share of common stock of the Issuer.
The restricted stock units were granted on August 3, 2016 and will vest as follows: (i) 27,381 on January 31, 2017 and (ii) 27,381 on January 31, 2018.
The restricted stock units were granted on August 3, 2016 and will vest on July 29, 2017.
/s/ Carl A. Valenstein, attorney-in-fact
2016-08-05